Revista Española de Cardiología (English Edition) Revista Española de Cardiología (English Edition)
Rev Esp Cardiol. 2007;60:139-47 - Vol. 60 Num.02 DOI: 10.1016/S1885-5857(07)60126-1

Comparison of the REGICOR and SCORE Function Charts for Classifying Cardiovascular Risk and for Selecting Patients for Hypolipidemic or Antihypertensive Treatment

Francisco Buitrago a, Lourdes Cañón-Barroso a, Natalio Díaz-Herrera a, Eloísa Cruces-Muro b, Miguel Escobar-Fernández a, José M Serrano-Arias a

a Unidad Docente de Medicina Familiar y Comunitaria, Centro de Salud Universitario La Paz, Servicio Extremeño de Salud, Badajoz, España,
b Unidad Docente de Medicina Familiar y Comunitaria, Centro de Salud Universitario La Paz, Servicio Extremeño de Salud, Badajoz, España,Unidad Docente de Medicina Familiar y Comunitaria, Centro de Salud Universitario La Paz, Servicio Extremeño de Salud, Badajoz, España,

Keywords

Cardiovascular risk. Coronary risk. SCORE risk chart. REGICOR risk chart.

Abstract

Introduction and objectives. In Spain, use of the Framingham-REGICOR (Registre Gironí del Cor) and SCORE (Systematic Coronary Risk Evaluation) risk charts is recommended for stratifying cardiovascular disease risk. The aims of the present study were to evaluate the degree of agreement between these charts when used to evaluate cardiovascular disease risk in nondiabetic individuals aged 40-65 years and to estimate the percentage of patients recommended for hypolipidemic or antihypertensive treatment. Methods. The study included 608 nondiabetic patients aged between 40-65 years (mean 52.8 years, 56.7% female) with no evidence of cardiovascular disease who were attending a primary healthcare center between 1990-1994. REGICOR and SCORE equations were used to calculate 10-year cardiovascular disease risks. Patients were classified as high-risk if their risk was ≥10% with REGICOR or ≥5% with SCORE. Results. Some 7.9% of the population was classified as high-risk with REGICOR and 9.2%, with SCORE (P=.41). Only 2.6% and 2.9% (P=.81) of women were classified as high-risk, compared with 14.8% and 17.5% of men, with REGICOR and SCORE, respectively (P=.40). The kappa coefficient was 0.45. According to European professional society guidelines, 23.8% of patients classified by SCORE and 23.0% classified by REGICOR (P=.73) would be recommended hypolipidemic treatment, while 31.2% and 31.7% (P=.85), respectively, would be recommended antihypertensive treatment. Conclusions. There was moderately good agreement between REGICOR and SCORE charts when used to evaluate nondiabetic individuals aged 40-65 years. They identified similar percentages of patients who would be recommended for hypolipidemic or antihypertensive treatment.

1885-5857/© 2007 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved

Cookies
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.
Cookies policy
x
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.